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Summary: We have evalüated an immunoturbidimetric method for the estimation of urinary albumin. The
method, besides being easy to perform and cost-effective, was sensitive enough to detect an even slightly
increased albumin excretion (detection limit 5 mg/1). Within-rün reproducibility was 1.8 and 2.1%, and
between-run reproducibility 2.9 and 4.3% in samples containing 16.1 — 17.8 mg/1 and 50.6 — 54.0 mg/1 of
albumin, respectively. The recovery of albumin added to the samples was 98.6 — 106.6%. Results obtained by
this method correlated well with the results obtained by radial immunodiffusion (r = 0.980, n = 44) and
radioimmunoassay (r = 0.982, n =41). The immunoturbidimetric method can be easily adapted for several
clinical chemistry analysers.
Introduction
Diabetic nephropathy is a serious late complication
in patients with Type l (insülin-dependent) diabetes
mellitus. Prospective studies have indicated that pa-
tients with micrpalbüminuria have an especially high
risk of developing clinical nephropathy (1) and that
constant microalbuminuria can be used äs a predictor
of nephropathy (l, 2, 3). Microalbuminuria may re-
gress (4, 5) by intensification of insulin treatment,
suggesting that the development of clinical nephro-
pathy can be postponed or avoided in these patients.
The determination of microalbuminuria has become
an important test for screening incipient nephropathy
in diabetics and in elinical follow-up studies. Hospital
testing for microalbuminuria is increasing rapidly, and
there is a need for a rapid and inexpensive method
which would be sensitive enough to measure minute
amounts of urinary albumin. Various techniques, in-
cluding radioiminunological (2, 6), enzyme immuno-
logical (7), immunonephelometric (8), immunoturbi-
dimetric (9,10,11) and radial immunodiffusion meth-
ods (12,13) have been introduced, but so far it is not
yet clear which one of the alternatives should be
preferred. Immunoturbidimetry is a simple and rapid
technique, in which the turbidity can be measured
with photometers which are common in clinical lab-
oratories, and the method is sensitive enough for
clinical purposes (11). In the present study we com-
päre a new sensitive immunoturbidimetric method
with a radioimmunological method and with a
method based on radial immunodiffusion.
Materials and Methods
Urine samples
24 hour urine samples were collected from 44 patients and 27
healthy volunteers. Samples were centrifuged and stored at
+ 4 °C, with thymol crystal added äs preservative.
Reagents
Antiserum (porcine anti-human-albumin serum), Reaction
Buffer, containing 5% polyethylene glycol 6000, and Human
Protein Reference Serum were all from Orion Diagnostica,
Espoo, Finland. Albustix® was from Ames Division, Miles
Laboratories Limited, Stoge Poges, Slough SL2 4LY, England.
Pharmacia Albumin RIA-kit was a kind gift from Pharmacia
AB, Uppsala, Sweden.
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Radioimmunoassay
The radioiramunoassay (RIA) was performed using 125I-labeled
albumin and the double antibody technique s recomraended
by the manufacturer. The activity of the samples was measured
with a NE 1612 Gamma Counter (Nuclear Enterprises LTD,
Sighthill, Edinburgh, U. K.) with an efficiency of 70 per cent.
Radial immunodiffusion
Radial immunodifTusion (RID) was performed according to
Mancini(\2\
Immunoturbidimetry
Immunoturbidimetric assays were carried out with a Multistat®
III F/LS Micro Centrifugal Analyser (Instrumentation Labo-
ratory, Ltd, Warrington, Cheshire, U. K.) and a FP-9 Clinical
Chemistry Analyser (Labsystems, Helsinki, Finland).
Preparation of samples, references and antiserum
reagent
Urine Specimens were centrifuged and then screened with Al-
bustix®. If the results were negative (albumin concentration
below 300 mg/1), the samples were used undiluted. If the results
were positive they w^re prediluted with saline tp correspond to
the assay r nge. The Human Protein Reference Serum was
diluted with saline to obtain an albumin concentration r nge
from 5 to 100 mg/1. Antiserum was diluted with Reaction Buffer
16-fold for the Multistat® III and 2-fold for the FP-9.
Assay procedures
Multistat® III
The loader settings were: 40 μΐ of sample were washed in with
20 μΐ of water, and 180 μΐ of antisera dilution were washed in
with 10 μΐ of water. Analyser settings were following:
Specific protein test tape
Wavelength 340 nm
Temperature 30 °C
Delay time 3 s
First read interval 3
Data time 60 s
Second read interval 5
Measuring time was 4 minutes. The results were calculated
automatically in milligrams per liter.
FP-9
350 μΐ of Reaction Buffer and 100 μΐ of urine sample or
reference were pipetted into cuvettes, mixed and incubated for
5 minutes (blank). The reaction was started by adding 50 μΐ of
antiserum dilution. Absorbances at 340 nm were read after 2
minutes. The results were calculated manually with the aid of
a reference curve.
Results
Reference curves
Typical reference curves for albumin obtained by the
immunoturbidimetric methods are shown in figure 1.
A measuring r nge of 5-100 mg/1 was selected for
microalbuminuria determinations. Although the de-
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Fig. 1. Reference curves for the determination of albumin by
immunoturbidimetry measured by the Multistat® III
F/LS Micro Centrifugal Analyser and by the FP-9 Clin-
ical Chemistry Analyser (o FP-9 and o Multistat® III).
tection limit is 5 mg/1, it is sensitive enough to detect
even slighty increased albumin excretion. The antigen
excess was reached at concentrations above 400 mg/1
s shown in figure 2.
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Fig. 2. Antigen excess curve of immunoturbidimetric urinary
° albumin assay (FP-9).
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Reproducibility
Precision studies were performed by using two pools
of urine with low and high albumin concentration.
Within-run reproducibilities varied from 1.8 to 2.1%,
and between-run reproducibilities were from 2.9 to
4.3% (tab. 1).
Correlations
The immunoturbidimetric method on the Multistat
III was compared with the radial immunodiffusion
method, radioimmunoassay, and with another im-
munoturbidimetric method (FP-9). Data are shown
in table 2 (r = 0.980, r = 0.982, and r = 0.983 for
Multistat® III versus RID, RIA and FP-9, respec-
tively). Figure 3 shows the correlation curve for Mul-
tistat® III versus RID.
Linearity
The linearity of the method was tested by serially
diluting pooled human urine of very high albumin
concentration with saline (tab. 3).
Analytical recovery
Known amounts of albumin were added to a pooled
urine specimen and assayed in duplicate. Albumin
recovery varied from 98.0 to 106.6% (tab. 4).
Tab. 1. Reproducibility of immunoturbidimetric assay of uri-
nary albumin using Multistat® III.
Albumin (mg/1)
Within-run
Between-run
Mean
16.1
50.6
17.8
54.0
SD
0.33
0.90
0.76
1.57
CV (%)
2.1
1.8
4.3
2.9
n
10
12
13
20
Tab. 2. Correlation of immunoturbidimetric urinary albumin
assay (Multistat® III) with radial immunodiffusion, ra-
dioimmunoassay, and another immunoturbidimetric
method (FP-9).
y/x
Multistat® III /RID
Multistat® III/RIA
Multistat® III/FP-9
n
44
41
44
r
0.980
0.982
0.983
Regression equation
y = 1.15x-4.18
y = 1.29x-3.34
y = 0.90x-4.26
Tab. 3. Linarity of immunoturbidimetric assay for urinary al-
bumin using Multistat® III.
Sample Albumin (mg/1)
Dilution
1
2
3
4
5
1/16
1056
—926
—
—
1/32
1140
2880
914
2688
2304
1/64
1030
3266
876
2802
2464
1/128
896
3261
870
2661
2367
1/256
3098
—
2685
2757
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Fig. 3. Correlation
ΠΙ) and
(y = 1.15x-4.18, r = 0.980, n = 44).
Tab. 4. Analytical recovery of urinary albumin by immunotur-
bidimetric assay using Multistat® III.
Albumin (mg/1)
Added
22.1
34.8
60.1
Recovered
21.8
35.2
64.1
Recovery (%)
98.6
101.1
106.6
Normal values
A d ily urinary albumin excretion study was con-
ducted with 27 healthy volunteers. 12 persons had
urinary albumin concentrations below 5 mg/1 and 15
persons from 5.4 to 15.9 mg/1 (from 6.3 to 16.4 mg/
24 hour). Three persons had a level above 10 mg/1.
These results agree well with earlier fmdings (8).
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Stabi l i ty of albumin in urine
Samples were prepared by adding varying amounts
of human serum albumin to a fresh urine sample.
Samples were stored at +4°C and -20°C. Meas-
urements were performed on freshly prepared samples
and on samples stored for one week, one month and
three months. the measuring ränge was extended to
160 mg/1 of albumin. As shown in table 5, the stability
of albumin in urine was good when the samples were
stored in a refrigerator and when they were frozen.
Tab. 5. Albumin stability in urine samples (FP-9). A normal
urine sample with and without an excess of albumin
was measured after storing one week, one month or
three months either in a refrigerator or in a freezer.
Albumin
added
(mg/1)
+ 4°C
0
15
50
100
200
-20°C
0
15
50
100
200
Beginning
7
23
'58
108
>160
1 week
7
22
58
115
>160
7
22
56
112
>160
1 month
7
22
56
103
>160
6
21
57
101
>160
3 months
6
21
50
92
>160
6
20
52
96
>160
Discussion
Radioimmunoassay is the method originally used (6)
in the detection of microalbuminuria. The method is
very sensitive, but has pitfalls common to all radioim-
munological methods. It is rather costly, relatively
slow, and the radioactive reagent deteriorates rapidly.
In addition, it involves precautions in handling of
radioactive material and special measuring equip-
ment.
Radial immunodiffusion, another method measuring
urinary albumin excretion, is cheaper but the pro-
longed incubating time makes the method rather im-
practical. Also, the immuiioreaction may be rather
difficult to read at low albumin concentrations, which
makes quantification inaccurate.
In contrast, the immunoturbidiinetric method is
cheap, rapid and suitable for serial analysis. No spe-
cial equipment is needed and this method can easily
be axiapted for several clinical chemistry analysers.
The albumin concentrations obtained by the immü-
noturbidimetric method (Multistat® III) correlated
closely with the values obtained by the radioimmu-
noassay and by the radial immunodiffusion method
(tab. 2), and also with another immunoturbidimetric
method (FP-9). The measuring ränge of 5-100 mg/1
is suitable for discriimnating the samples with normal
albumin concentrations from those with slightly ele-
vated values. The method was highly reprodücible
even at the high normal urinary albumin concentra^
tion (x = 16.1 mg/1, CV = 2.1%, n = 10).
The rather high limit of antigen excess (400 mg/1)
allows the determination of all Albustix®-negative
samples (albumin concentration below 300 mg/1) with-
out prior dilution of the sample. Albustix®-negative
samples with albumin concentrations higher than 100
mg/1 should then be diluted 4-fold and the test should
be repeated within the optimal measurinig ränge (fig.
1). Albustix®-positive samples can be measured with
appropriate dilution of the samples prior to analysis.
In this way the number of off-scale samples is min-
imised. The immunoturbidimetric method should be
especially suitable for use in the out-patient depart^
ment and during duty activity where a rapid and
simple method is needed.
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